These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12012751)

  • 21. Increasing severity of cardiac autonomic neuropathy is associated with increasing prevalence of nephropathy, retinopathy, and peripheral neuropathy in Turkish type 2 diabetics.
    Bilal N; Erdogan M; Ozbek M; Cetinkalp S; Karadeniz M; Ozgen AG; Saygili F; Yilmaz C; Tüzün M; Kabalak T
    J Diabetes Complications; 2008; 22(3):181-5. PubMed ID: 18413163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic nephropathy: a nephrological point of view.
    Chanard J
    Diabetes Metab; 2000 Jul; 26 Suppl 4():4-5. PubMed ID: 10922966
    [No Abstract]   [Full Text] [Related]  

  • 23. [Diabetic nephropathy: glomerular filtration rate and estimated creatinine clearance].
    Guimarães J; Bastos M; Melo M; Carvalheiro M
    Acta Med Port; 2007; 20(2):145-50. PubMed ID: 17868520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diabetic nephropathy. A matter of inflammation?].
    Navarro J
    Nefrologia; 2003; 23(5):381-9. PubMed ID: 14658163
    [No Abstract]   [Full Text] [Related]  

  • 25. Renal microvascular and tubular injuries in type II diabetic nephropathy.
    Futrakul N; Futrakul P
    Kidney Int; 2008 Aug; 74(3):390; author reply 390-1. PubMed ID: 18626500
    [No Abstract]   [Full Text] [Related]  

  • 26. Diabetic nephropathy: what are the diabetologist's expectations?
    Passa P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():6. PubMed ID: 10922967
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diabetes mellitus, hypertension and kidney].
    Monhart V
    Vnitr Lek; 2008 May; 54(5):499-504, 507. PubMed ID: 18630636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adequate vascular repair is relevant to improving renal perfusion and function following vasodilators in normoalbuminuric type 2 diabetic nephropathy.
    Futrakul N; Futrakul P
    Am J Kidney Dis; 2009 Sep; 54(3):583-4. PubMed ID: 19700066
    [No Abstract]   [Full Text] [Related]  

  • 31. Obesity, diabetes, adiponectin and the kidney: a podocyte affair.
    Zoccali C; Mallamaci F
    Nephrol Dial Transplant; 2008 Dec; 23(12):3767-70. PubMed ID: 18802210
    [No Abstract]   [Full Text] [Related]  

  • 32. Anaemia is common and predicts mortality in diabetic nephropathy.
    Joss N; Patel R; Paterson K; Simpson K; Perry C; Stirling C
    QJM; 2007 Oct; 100(10):641-7. PubMed ID: 17921197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis].
    Shestakova MV; Koshel' LV; Vagodin VA; Dedov II
    Ter Arkh; 2006; 78(5):60-4. PubMed ID: 16889052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy.
    Sawai K; Mukoyama M; Mori K; Yokoi H; Koshikawa M; Yoshioka T; Takeda R; Sugawara A; Kuwahara T; Saleem MA; Ogawa O; Nakao K
    Nephrol Dial Transplant; 2006 Sep; 21(9):2472-7. PubMed ID: 16820374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating diabetic nephropathy: unfinished success is not failure.
    Lewis J
    Clin J Am Soc Nephrol; 2007 May; 2(3):407-9. PubMed ID: 17699442
    [No Abstract]   [Full Text] [Related]  

  • 37. Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy.
    Kimura T; Ikeda H; Fujikawa J; Nomura K; Aoyama T; Wada Y; Nabe K; Hamamoto Y; Honjo S; Koshiyama H
    Diabetes Res Clin Pract; 2009 Feb; 83(2):e58-61. PubMed ID: 19118914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes and the kidney.
    O'Connor AS; Schelling JR
    Am J Kidney Dis; 2005 Oct; 46(4):766-73. PubMed ID: 16183435
    [No Abstract]   [Full Text] [Related]  

  • 39. Achieved vs initial blood pressure in predicting renal outcomes.
    Onuigbo MA
    Arch Intern Med; 2004 Jan; 164(2):223; author reply 223-4. PubMed ID: 14744850
    [No Abstract]   [Full Text] [Related]  

  • 40. [The kidney as a target organ in diabetic patients with arterial hypertension].
    Viberti G
    Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.